Is there a role for Ethics Committees in Early Access?
Lorem ipsum dolor sit amet, consectetur adipiscing elit....
Read More
Elevar Therapeutics Inc. Announces Licensing Agreement with Inceptua Group
Lorem ipsum dolor sit amet, consectetur adipiscing elit....
Read More
Inceptua Q&A: What is Early Access?
Lorem ipsum dolor sit amet, consectetur adipiscing elit....
Read More
Inceptua Partners with Global Blood Therapeutics for an Early Access Program for Voxelotor for Patients with Sickle Cell Disease
Lorem ipsum dolor sit amet, consectetur adipiscing elit....
Read More
Webinar: Strategic Comparator Sourcing in China
Lorem ipsum dolor sit amet, consectetur adipiscing elit....
Read More
Safely and Reliably Supplying your Comparator Needs during COVID19
Lorem ipsum dolor sit amet, consectetur adipiscing elit....
Read More
Maintaining access to your medicines during COVID19
Lorem ipsum dolor sit amet, consectetur adipiscing elit....
Read More
Helping get orphan drugs to patients quicker
Lorem ipsum dolor sit amet, consectetur adipiscing elit....
Read More
Inceptua receives approval of marketing authorization transfer of Jetrea® (ocriplasmin) for the treatment of symptomatic vitreomacular adhesion
Lorem ipsum dolor sit amet, consectetur adipiscing elit....
Read More
Inceptua Group Announces Partnership with BioCryst on Expanded Access Program for Patients with Hereditary Angioedema
Lorem ipsum dolor sit amet, consectetur adipiscing elit....
Read More
Global License Agreement a Building Block in Strategic Growth Plans
Lorem ipsum dolor sit amet, consectetur adipiscing elit....
Read More
How we are supporting with uninterrupted supply of medicines for clinical trials
Lorem ipsum dolor sit amet, consectetur adipiscing elit....
Read More
Oxurion and Inceptua Group enter global license agreement for the commercialization of JETREA®
Lorem ipsum dolor sit amet, consectetur adipiscing elit....
Read More
Industry Trends in Early Access to Medicines
Lorem ipsum dolor sit amet, consectetur adipiscing elit....
Read More
Inceptua and Portola enter exclusive distribution agreement for Ondexxya®
Lorem ipsum dolor sit amet, consectetur adipiscing elit....
Read More